Speaker: Andrea Nance, MPH, RN, Sustainability Lead for Global Safety, Health and Environment, AstraZeneca
Presentation Outline
- Who we are: company background
- Early journey: Community Investment and CSR early commitments
- First “sustainability” launch: Global Sustainability function in 2015
- Rationale and early ambitions
- Building: first materiality assessment and launch of first report in 2016
- Identifying gaps, aligning to SDGs, taking a leadership stance
- Defining what sustainability means to a biopharmaceutical company
- Evolving: building an updated strategy in a short period of time
- Being bold: Launch of Making Science Accessible
- Lessons learned and next steps
Key Takeaways
- Developing a sustainability strategy is often a long journey, with many lessons learned, adaptations, and much research/collaboration
- AstraZeneca’s journey is based on what our role is as a biopharmaceutical company: each industry has a unique approach
- SDGs provide a compass on how to achieve a balanced approach to the most pressing global issues
- We must collaborate, consult, listen, learn, and continue to grow to meet the challenges facing our industries and world today.